Antithrombotic therapy post-TAVI suboptimal: Aus study
More evidence is needed on real-world outcomes for use of prophylactic drugs to better guide practice, researchers say
![](https://www.ausdoc.com.au/wp-content/uploads/2022/08/senior-old-man-patient-medicine-pill-dreamstime_s_198743568-1.jpg)
One in three Australians undergoing transcatheter aortic valve implantation miss out on guideline-recommended antithrombotic therapy post-discharge, a study shows.
Sydney researchers say local rates of antithrombotic use following the procedure appear to be lower than those reported internationally, with significant room for improvement.